‘Caution folks’: Top WHO scientist flags ‘dangerous trend’ of mixing Covid-19 vaccines

Geneva, July 12 (ANI): Mixing and matching COVID-19 vaccines from different manufacturers is a “dangerous trend” and could lead to chaos as there is limited data on it on the practice, World Health Organisation (WHO) chief scientist Soumya Swaminathan said on Monday.

Addressing a Covid-19 media briefing, Swaminathan said, “Really want to caution folks, because there is a tendency now for people in countries which enough availability of vaccines to voluntarily start thinking.”

“So it’s a little bit of a dangerous trend here where we’re in a data-free evidence-free zone as far as a mix and match there is limited data on mix and match. There are studies going on, we need to wait for that,” she added.

On the question of booster shots, WHO chief scientist said it will be a chaotic situation in countries if citizens start deciding when they should be taking a second, or a third, or a fourth dose.

“We have four countries that have announced a booster program, and a few more that are thinking about it. If 11 high and upper-middle-income countries decide to some of them are large countries that they will go for a booster for their populations or even subgroups. This will require an additional 800 million doses of vaccine.”

Stressing on the need to prioritise vaccines, Swaminathan said there are still countries where the frontline and health care workers have not been vaccinated and the elderly and the vulnerable.”

The world has so far witnessed over 186 million cases and four million deaths due to the virus, according to the Johns Hopkins University‘s data. (ANI)

  • Related Posts

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

    Diabetic drug metformin found to act on brain

    NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory